The makers of the only birth control patch announced last week that new studies have shown that their Ortho Evra birth Control Patch is having twice the problems of the standard oral dose. Ortho Women’s Health & Urology is the maker of the ORTHO EVRA (R) (norelgestromin/ethinyl estradiol transdermal system) birth control patch and it has received findings from two separate studies that were designed to evaluate the risk of experiencing serious side effects when using this form of hormonal birth control therapy. Read more at Ortho Evra Admits Increased Risk.
These findings should not be surprising given the lack of sufficient studies before the patch was released and the number of problems reported with the use of the patch.
Comments for this article are closed.